Oculis Holding (OCS) Live Share Price, Invest From India

Oculis Holding Stock Performance

as on October 31, 2026 at 2:16 pm IST

Day's Low
Day's High
$8.19
Day's Price Range
$8.84
$8.26
0.85%
Downside
7.02%
Upside
52 Week's Low
52 Week's High
$7.11
52-Week Price Range
$34.48
$8.26
13.92%
Downside
317.37%
Upside

Oculis Holding share price movements today

Previous Close: $8.24
Open: $8.19
Volume: 505.5K
Market Cap: $491.5M
Day's Low - High: $8.19 - $8.84
52 Week Low - High: $7.11 - $34.48

Oculis Holding Historical Returns

1 Month Return: -11.78 %
3 Month Return: -26.49 %
1 Year Return: -58.98 %
3 Year Return: -16.77 %
5 Year Return: 0 %

Oculis Holding Stock Fundamentals & Key Indicators

Check Oculis Holding market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$491.5M

EPS (TTM)

-1.4

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-4.73

Industry PE ratio

-7.60

PEG Ratio

-0.08

EBITDA

-78.3M

Revenue (TTM)

243.0K

Profit Margin

35.21%

Return On Equity TTM

-42.92%

Oculis Holding vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Oculis Holding with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Oculis Holding	StrongBuy	$491.5M	NA	-4.73	35.21%	0.00%
Moderna	Neutral	$85.5B	-35.47%	-26.84	-12.57%	0.00%
Vertex Pharmaceuticals	StrongBuy	$134.2B	192.00%	30.58	86.04%	0.00%
Regeneron	Buy	$83.7B	27.94%	19.42	84.86%	0.45%

Stock Returns calculator for Oculis Holding Stock including INR - Dollar returns

The Oculis Holding stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Oculis Holding investment value today

Current value as on today

₹43,978

Returns

-₹56,022

(-56.02%)

Returns from Oculis Holding Stock

-₹58,885 (-58.89%)

Dollar Impact

₹2,863 (+2.86%)

Analyst Recommendation on Oculis Holding Stock

Based on 6 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 6 analysts, 100% of analysts recommend a 'BUY' rating for Oculis Holding. Average target price of $36.87

Oculis Holding Share Price Target

Get share price movements and forecasts by analysts on Oculis Holding.

What analysts predicted

77.6%UPSIDE

Target Price

$36.87

Current Price

$8.26

Analyzed by

6 Analysts

High

$45

Target

$36.87

Low

$20

Oculis Holding target price $36.87, a slight upside of 77.6% compared to current price of $8.26. According to 6 analysts rating.

Indian Investors' Interest in Oculis Holding Stock

Search interest for Oculis Holding Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.

Time period: October 2, 2026 to November 1, 2026

Change:-37% versus previous 30 day period

Oculis Holding Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	0	0	-	-	-
Gross Profit	-	-	-	-	-	-14	0	-	0	-
Operating Income	-15	-22	-18	-17	-19	-20	-20	-20	-22	-23
EBITDA	-15	-20	-19	-28	-32	-25	-16	-23	-29	-9
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-16	-20	-20	-28	-33	-25	-16	-23	-29	-9
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-16	-20	-20	-28	-33	-25	-16	-23	-29	-9
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-5612.26%	100.00%	0.00%	0.00%	0.00%

Oculis Holding Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	0	-
Gross Profit	-	-	-	-	-51	-
Operating Income	-12	-13	-32	-80	-73	-79
EBITDA	-12	-13	-31	-87	-85	-93
Interest Expense	2	5	6	1	0	0
Depreciation	0	0	0	0	0	0
Income Before Tax	-14	-18	-38	-88	-85	-94
Income Tax Expense	0	0	0	0	0	0
Net Income	-14	-18	-38	-88	-85	-94
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-7492.27%	0.00%

Oculis Holding Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	-16	-20	-20	-28	-33	-25	-16	-23	-29	-9
Operating Cash Flow	-13	-13	-10	-10	-18	-17	-13	-16	-15	-20
Investing Cash Flow	-1	-18	4	-1	-51	25	-2	-32	-26	-8
Financing Cash Flow	0	51	0	2	103	0	-1	84	24	25
Change in Cash	-13	19	-8	-7	32	4	-17	34	-17	-2

Oculis Holding Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-14	-18	-38	-88	-85	-94
Operating Cash Flow	-12	-13	-25	-53	-47	-62
Investing Cash Flow	0	0	-3	-54	-17	-59
Financing Cash Flow	4	55	1	129	54	178
Change in Cash	-7	41	-26	18	-10	57

Global Institutional Holdings in Oculis Holding

Check out the Institutions with significant holdings in Oculis Holding.

Funds	Holdings
Joseph Edelman	1.31%
Franklin Strategic Series	0.51%
Michael Rockefeller	0.33%
VANGUARD WHITEHALL FUNDS	0.17%
ALPS	0.12%

See all

Insights on Oculis Holding

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -29.49M → -9.96M (in $), with an average increase of 195.8% per quarter
NO EFFECT
Against Peers
In the last 1 year, Moderna, Inc. Common Stock has given 720.2% return, outperforming this stock by 777.5%
NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 193.3% return, outperforming this stock by 209.2%
NEGATIVE IMPACT
Price Dip
In the last 6 months, OCS stock has moved down by -70.0%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 261.0K → 243.0K (in $), with an average decrease of 6.9% per quarter

About Oculis Holding

Oculis Holding AG is a biopharmaceutical company in the clinical development stage, specializing in the creation of innovative eye drop medications for various ocular conditions, addressing both the anterior and posterior segments of the eye. A key asset in its therapeutic portfolio is OCS-01, a topical formulation of dexamethasone, currently progressing through Phase 3 clinical trials for the management of diabetic macular edema. Additionally, OCS-02, a topically administered biological candidate, is engaged in Phase 2b clinical studies to treat keratoconjunctivitis sicca, commonly known as dry eye disease. The company is also advancing OCS-05, an innovative neuroprotective agent, which targets acute optic neuritis and an array of other neuro-ophthalmic disorders, including glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. This enterprise maintains its headquarters in Zug, Switzerland.

Organisation	Oculis Holding
Headquarters	Bahnhofstrasse 7, Zug, ZG, 6300, CH
Industry	Biotechnology
CEO	Riad Sherif

Key Management of Oculis Holding

Name	Title
Dr. Ramin Tadayoni M.D., Ph.D.	Chief Scientific Officer
Ms. Katie Kazem	Chief Legal Officer
Dr. Snehal Shah Pharm.D.	President of Research & Development
Ms. Rebecca Weil Ph.D.	Chief Commercial Officer
Dr. Sharon Klier M.D., M.P.H.	Chief Development Officer
Dr. Riad Sherif M.B.A., M.D.	CEO & Director
Ms. Sylvia Cheung	Chief Financial Officer
Ms. Gudrun Bachmann Ph.D.	Chief Technology Officer
Ms. Virginia R. Dean	Chief Human Resources Officer
Mr. Páll Ragnar Jóhannesson	Chief Business Officer

FAQs

What is Oculis Holding share price today?

Oculis Holding share price today is $8.26 as on October 31, 2026 at 8:46 am IST at the close of the market. Oculis Holding share today touched a day high of $8.84 and a low of $8.19.

What is the 52 week high and 52 week low for Oculis Holding share?

Oculis Holding share touched a 52 week high of $34.48 on May 11, 2026 and a 52 week low of $7.11 on October 14, 2026. Oculis Holding stock price today i.e. October 31, 2026 at 8:46 am IST is closed at $8.26,which is 76.04% down from its 52 week high and 16.17% up from its 52 week low.

What is Oculis Holding's market capitalisation today?

Oculis Holding market capitalisation is $0.00T as on October 31, 2026 at 8:46 am IST.

How to invest in Oculis Holding Stock (OCS) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Oculis Holding on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Oculis Holding Stock (OCS) from India?

Indian investors can start investing in Oculis Holding (OCS) shares with as little as ₹94.94999694824219 or $1 (as of November 1, 2026 at 2:37 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹949.50 in Oculis Holding stock (as per the Rupee-Dollar exchange rate as on November 1, 2026 at 2:37 am IST). Based on Oculis Holding share’s latest price of $8.26 as on October 31, 2026 at 8:46 am IST, you will get 1.2107 shares of Oculis Holding. Learn more about fractional shares .